FDA approves new Alzheimer's drug, offering hope for slower cognitive decline

The U.S. Food and Drug Administration gave a green light to Eli Lilly's donanemab for patients with early Alzheimer's, making it the second approved drug for slowing the progress of the brain-wasting disease.

Jul 2, 2024 - 23:00
 0  3
FDA approves new Alzheimer's drug, offering hope for slower cognitive decline
White office building with glass windows, and a white sign with word Lilly in red cursive letters

The U.S. Food and Drug Administration gave a green light to Eli Lilly's donanemab for patients with early Alzheimer's, making it the second approved drug for slowing the progress of the brain-wasting disease.

What's Your Reaction?

like

dislike

love

funny

angry

sad

wow